A phase II trial of conventional radiation therapy (XRT) plus high dose tamoxifen (TAM) for the treatment of supratentorial glioblastoma multiforme (GBM): RTOG protocol BR-0021

被引：0
|
作者：
Robins, H [1 ]
Won, N [1 ]
Seiferheld, W [1 ]
Schultz, C [1 ]
Choucair, A [1 ]
Brachman, D [1 ]
Demas, W [1 ]
Mehra, MP [1 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
来源：
NEURO-ONCOLOGY | 2004年 / 6卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：363 / 363
页数：1
相关论文
共 50 条
  • [1] A phase II trial of conventional radiation therapy (XRT) plus high dose tamoxifen (TAM) for the treatment of supratentorial glioblastoma multiforme (GBM): RTOG protocol BR-00211.
    Robins, HI
    Won, M
    Schultz, C
    Choucair, A
    Brachman, D
    Demas, W
    Mehta, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 114S - 114S
  • [2] Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021
    Robins, HI
    Won, M
    Seiferheld, WF
    Schultz, CJ
    Choucair, AK
    Brachman, DG
    Demas, WF
    Mehta, MR
    NEURO-ONCOLOGY, 2006, 8 (01) : 47 - 52
  • [3] Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-β for supratentorial glioblastoma:: Results of RTOG 9710
    Colman, Howard
    Berkey, Brian A.
    Maor, Moshe H.
    Groves, Morris D.
    Schultz, Christopher J.
    Vermeulen, Sandra
    Nelson, Diana F.
    Mehta, Minesh P.
    Yung, W. K. Alfred
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : 818 - 824
  • [4] Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme
    Langer, CJ
    Ruffer, J
    Rhodes, H
    Paulus, R
    Murray, K
    Movsas, B
    Curran, W
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (01): : 113 - 119
  • [5] Phase I/II study of enzastaurin (ENZ) plus temozolomide (TMZ) and radiation therapy (XRT) in patients with glioblastoma multiforme (GBM) or gliosarcoma (GS)
    Butowski, N. A.
    Lamborn, K.
    Chang, S.
    Page, M.
    Rabbitt, J.
    Fedoroff, A.
    Parvataneni, R.
    Nicol, S. J.
    Thornton, D.
    Prados, M. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] PHASE I/II STUDY OF ENZASTAURIN (ENZ) PLUS TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (XRT) IN PATIENTS (PTS) WITH GLIOBLASTOMA MULTIFORME (GBM) OR GLIOSARCOMA (GS)
    Butowski, N.
    Lamborn, K.
    Chang, S.
    Page, M.
    Parvataneni, R.
    Chang, S.
    Liepa, A. M.
    Nicol, S.
    Thornton, D.
    Prados, M.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1073 - 1074
  • [7] A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806)
    Brian M. Alexander
    Meihua Wang
    W. K. Alfred Yung
    Howard A. Fine
    Bernadine A. Donahue
    Ivo W. Tremont
    Ray S. Richards
    Kevin J. Kerlin
    Alan C. Hartford
    Walter J. Curran
    Minesh P. Mehta
    Journal of Neuro-Oncology, 2013, 111 : 33 - 39
  • [8] A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806)
    Alexander, Brian M.
    Wang, Meihua
    Yung, W. K. Alfred
    Fine, Howard A.
    Donahue, Bernadine A.
    Tremont, Ivo W.
    Richards, Ray S.
    Kerlin, Kevin J.
    Hartford, Alan C.
    Curran, Walter J.
    Mehta, Minesh P.
    JOURNAL OF NEURO-ONCOLOGY, 2013, 111 (01) : 33 - 39
  • [9] Treatment of supratentorial glioblastomas multiforme with the association of BCNU and low or high dose of tamoxifen: A phase II study
    Napolitano, M
    Keime-Guibert, F
    Lafitte, C
    Ameri, A
    Cornu, P
    Delattre, JY
    NEUROLOGY, 1998, 50 (04) : A352 - A352
  • [10] Phase II trial of radiation therapy/temozolomide followed by temozolomide/sorafenib in the first-line treatment of glioblastoma multiforme (GBM)
    Lamar, R. E.
    Spigel, D. R.
    Burris, H. A.
    Markus, T. M.
    Kuzur, M.
    Ervin, T.
    Fichtel, L.
    Greco, F. A.
    Hainsworth, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345